CVE-2017-1692

CVE-2017-1692 is a high-severity vulnerability in Ibm Aix with a CVSS 3.x base score of 7.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Description

IBM AIX 5.3, 6.1, 7.1, and 7.2 contains an unspecified vulnerability that would allow a locally authenticated user to obtain root level privileges. IBM X-Force ID: 134067.

Frequently asked questions

What is CVE-2017-1692?
IBM AIX 5.3, 6.1, 7.1, and 7.2 contains an unspecified vulnerability that would allow a locally authenticated user to obtain root level privileges. IBM X-Force ID: 134067.
How severe is CVE-2017-1692?
CVE-2017-1692 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2017-1692 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (29th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2017-1692?
CVE-2017-1692 primarily affects Ibm Aix. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2017-1692?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2017-1692 published?
CVE-2017-1692 was published on 2018-02-07 and last updated on 2026-06-17.

References

Affected products (4)

More vulnerabilities in Ibm Aix

All CVEs affecting Ibm Aix →